Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof

Abstract

The invention discloses a new clause of a five membered heterocylic ring compounds of general formula I and its pharmaceutically or cosmetically acceptable salts, wherein R1, R2, R3, R4, R5, A, B, X and Y are as defined in the specification. The invention also discloses a process for preparation of these compound and their therapeutic and cosmetic applications particularly in the management of aging related and diabetic vascular complications. The compounds in question act by triple action of an AGE (Advanced Glycation Endproducts) breaker, AGE inhibitor and free radical scavenger which make them most suitable in different therapeutic and cosmetic applications. The invention also discloses pharmaceuticals and cosmetic compositions comprising these compounds and method of treatment of diseases caused by accumulation of AGE and / or free radicals in the body cells.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application is a divisional of U.S. application Ser. No. 10 / 116,135 filed Apr. 5, 2002, which claims benefit from U.S. provisional Application No. 60 / 281,380 filed Apr. 5, 2001; the above-noted applications incorporated herein by reference in their entirety.BACKGROUND OF THE INVENTION [0002] 1. Field of the Invention [0003] The present invention relates to a new class of compounds of five membered heterocyclic ring compounds and to their use in treatment of diabetes and related illnesses. More particularly the invention relates to compounds of this series, methods for their preparation, pharmaceutical composition containing these compounds and their use in the treatment of complications of diabetes mellitus. The compounds of this series exhibit AGE breaking and inhibiting activity, which is essential for the treatment of diabetic and aging-related vascular and neurovascular complications including kidney disease, nerve damage, athe...

AI Technical Summary

Benefits of technology

The present invention provides a new class of five membered heterocyclic ring compounds that can be used for the management of diabetes and aging related vascular complications. These compounds have been found to have AGE breaking and inhibiting activities, and can be used in the treatment of diabetic patients, as well as in cosmetic compositions. The invention also provides pharmaceutical compositions and methods for scavenging free radicals and inhibiting AGE. The technical effects of the invention include the development of new compounds with improved therapeutic and cosmetic effects, as well as methods for their use in managing diabetes and related complications.

Problems solved by technology

In addition, the activity of several growth factors, such as basic fibroblast growth factor, is also impaired.

The unchecked formation of AGE in vivo, such as in diabetics related diseases, can lead to severe physiological impairment.

Similarly, on the other hand, non-enzymatic cross-linking of structural proteins, such as collagen, leads to increased stiffness of arteries and reduce arterial compliance and distensibility.

The nonenzymatic browning reaction, which occurs in the oral cavity, results in the discoloration of teeth.

Renal disease is a leading cause of death and diability in diabetes.

AGE's contribute to the development of abnormal fibrous tissue and reduces the ability of the peritoneum to filter fluids, leading to a failure of the PD procedure.

When both elastin and collagen are at scarce and damaged, the skin looses its shape after being stretched or folded leading to wrinkles and facial sag that happens during the process of aging.

Skin, a highly differentiated and complexly structured organ, is particularly vulnerable to free radical damage on exposure to UV radiation resulting in an increased accumulation of AGEs on the skin as well as an increased production of singlet oxygen and super oxide radicals which damage the important skin molecules such as collagen and elastin.

As a consequence, the skin becomes dry and scaly.

In addition, the ability of the skin to repair itself diminishes with age, so wounds are slower to heal.

During the aging process reducing sugar chemically attaches to the skin's support proteins like elastin and collagen, causing them to become gradually rigid and slowing their renewal.

As a result of this aging process, collagen loses its elasticity and the skin develops wrinkles.

The covalent binding of glucose to the amino group of protein alone is not sufficient to account for structural changes observed in collagen.

Skin, which has a highly differentiated and certainly complex organizational structure, is particularly vulnerable to free radical damage because of its contact with oxygen and other environmental stimuli (Calabrese V, Scapagnini G et. al., Drugs Exp.

It forms a vicious cycle by increasing the accumulation of AGEs on the skin as well as increased production of singlet oxygen and super oxide radicals, which damage the skin protein.

These radicals disrupt the natural balance of the skin by stimulating the skin cells to synthesize metalloproteinases.

The unbalanced production of metalloproteinase over anti-metalloprotenases induced by singlet oxygen free radicals leads to break down of collagen and elastin of the skin.

The shelves in the cosmetics market are full of products treating extrinsic aging, but there is still a vacuum for a product, which targets intrinsic aging by inhibiting AGE in skin support proteins.

Although free radicals have an important role in normal physiologic mechanisms, the excessive production of ROS results in oxidative stress—the terms usually applied to the out come of oxidative damage to biologically important molecules, such as protein, lipids, and nucleic acids.

Proteins have long been known to be susceptible to oxidation by ROS.

Aromatic amino acids like cystine, and disulfide bonds are particularly vulnerable.

They are highly susceptible to damage by ROS.

One of the leading hypotheses is that oxidative stress induced by Relative Oxygen Species (ROS) damages essential components of the neurons, resulting ultimately in the neuronal death.

Oxidative stress in diabetes is also increased due to weakened defenses due to reduced endogenous antioxidants.

These free radicals impair vascular relaxation by inactivating or quenching nitric oxide (NO) and also adversely affect the endothelial function.

Similarly, sublethal acute oxidative injury may produce unrepaired DNA damage and result in the formation of new mutations and, potentially, new initiated cells.

ROS, therefore, can have multiple effects in the initiation stage of carcinogenesis by mediating carcinogen activation, causing DNA damage, and interfering with the repair of the DNA damage.

Animal studies have provided evidence by suggesting that free radicals may promote thrombosis, directly damage vascular cells and other tissues, and interfere with vasomotor regulation with the clinical sequelae of myocardial infarction and ischemic stroke.

Thus biochemical damage due to free radicals contributes to the ischemic injury.

Oxidative stress also seems to be one of the mechanisms that may produce membrane defects and result in intracellular calcium overload, and cardiac contractile dysfunction in the stunned myocardium.

Peroxidation of cell membranes compromises membrane integrity and disrupts intracellular signaling.

Images